ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 41 filers reported holding ACRIVON THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 1,652,605 | $21,417,761 | 6.34% |
| RA Capital Management | 4,810,508 | $62,344,184 | 1.18% |
| Perceptive Advisors | 3,007,858 | $38,981,840 | 1.13% |
| NEA Management Company, LLC | 481,677 | $6,242,534 | 0.48% |
| DAFNA Capital Management LLC | 76,852 | $996,002 | 0.27% |
| AAF Wealth Management, LLC | 10,678 | $138,387 | 0.09% |
| UBS OCONNOR LLC | 100,000 | $1,296,000 | 0.04% |
| MARSHALL WACE, LLP | 597,469 | $7,743,198 | 0.02% |
| FEDERATED HERMES, INC. | 304,411 | $3,945,167 | 0.01% |
| Citadel Advisors | 1,649,646 | $21,379,412 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 11,709 | $151,749 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 888,130 | $11,510,165 | 0.00% |
| D. E. Shaw & Co., Inc. | 46,910 | $607,954 | 0.00% |
| NORTHERN TRUST CORP | 68,678 | $890,067 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Legal & General Group Plc | 839 | $10,873 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 178,453 | $2,312,750 | 0.00% |
| STATE STREET CORP | 125,976 | $1,632,649 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,275 | $29 | 0.00% |
| STRS OHIO | 800 | $10 | 0.00% |
This page lists ACRIVON THERAPEUTICS INC's shareholders in Q2 2023. To view ACRIVON THERAPEUTICS INC's shareholder history, click here.